MetLife director granted 587 shares in stock award
Hay Laura J reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Hay Laura J reported acquisition or exercise transactions in this Form 4 filing.
MetLife Inc. director Laura J. Hay received an award of 587 shares of MetLife common stock as part of non-management director compensation. The shares were valued at $87.40 per share on the grant date. Following this award, Hay directly holds 6,318 shares of MetLife common stock. According to the disclosure, she elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors, meaning the grant is part of standard board retainer fees rather than an open-market purchase.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 587 | $87.40 | $51K |
Footnotes (1)
- F1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.
Key Figures
Key Terms
non-management director compensation arrangements financial
retainer fees financial
MetLife Deferred Compensation Plan for Non-Management Directors financial
grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did MetLife (MET) director Laura J. Hay report?
At what price was Laura J. Hay’s MetLife (MET) stock award valued?
Was Laura J. Hay’s MetLife (MET) transaction an open-market buy or a compensation grant?
Did Laura J. Hay defer her MetLife (MET) stock award under a company plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.